Literature DB >> 3326630

Attempts to establish phage typing as an epidemiological marker for Salmonella enteritidis.

R Alonso1, A Echeita, P Espinosa, M A Usera.   

Abstract

The notable increase in the number of Salmonella enteritidis strains seen in Spain in recent years (from 27.10% in 1980 to 66.36% in 1985) makes it necessary to find an additional epidemiological marker for this serotype. Phage typing was considered because of its discriminatory capacity toward other Salmonella serotypes. Wild and lysogenic bacteriophages were sought for a set of autochthonous bacteriophages. Our set consisted of 6 bacteriophages, 5 wild and 1 lysogenic. When tested on 1,500 selected strains, they produced 9 different phage types. The most abundant phage types were A (74.66%) and B (19.73%). The percentage of non-typable strains was low: only 1.4% from a total of 1,500 strains failed to produce lysis with our set. This reflects the high typability of the bacteriophage set proposed.

Entities:  

Mesh:

Year:  1987        PMID: 3326630     DOI: 10.1016/0769-2609(87)90043-3

Source DB:  PubMed          Journal:  Ann Inst Pasteur Microbiol        ISSN: 0769-2609


  4 in total

1.  Epidemiological differentiation of pathogenic strains of Salmonella enteritidis by ribotyping.

Authors:  E Landeras; M A González-Hevia; R Alzugaray; M C Mendoza
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

2.  Correlation of conversion of Salmonella enterica serovar enteritidis phage type 1, 4, or 6 to phage type 7 with loss of lipopolysaccharide.

Authors:  D L Baggesen; H C Wegener; M Madsen
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Differentiation of strains from a food-borne outbreak of Salmonella enterica by phenotypic and genetic typing methods.

Authors:  M A Gonzalez Hevia; M C Mendoza
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

4.  Distribution of Salmonella enteritidis phage types in Canada.

Authors:  R Khakhria; D Duck; H Lior
Journal:  Epidemiol Infect       Date:  1991-02       Impact factor: 2.451

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.